actually, upon closer inspection, I think we're a very solid...

actually, upon closer inspection, I think we're a very solid chance to get to 11m revenue. Page 4 of this pres shows that full curriculum brought in about $2.1mill in H2, therefore we can conservatively assume that we will match (if not modestly beat) that sum + the ~$4.5m from the VET courses (assuming the numbers are correct) and that alone equates to about $7mill + the $3.5m from H1, leaves us with $10.5m revenue. We know that there's a greater skew to H2 than in past years due to the reasons mentioned in the half yearly and therefore can surmise that we will be very close to beating the $7.4mill of FY20 by ~40-50%.

I think the fact that the co has decided to invest in the VET space with AIET and COSAMP is a clear indication of where they see the low hanging fruit lies. There are greater margins there helping this co go a long way to getting past it's inflection point. I'm assuming that VET courses will make up more than half of the co's revenue in FY22.